Noveko closes private placement for $595,104

NewsGuard 100/100 Score

Noveko International Inc. (TSX: EKO) (the "Company") announces a first closing of $595,104 of its private placement. Additional closings are expected until May 23, 2011.

Pursuant to this first closing, 850,148 Class A shares were issued and an additional 425,074 Class A shares may be issued upon due exercise of the Warrants. The securities issued pursuant to this private placement are subject to a mandatory four-month hold period.

"We remain confident we will achieve our financing objectives as the offering extends until May 23rd. Although the results of this first closing are below our expectations, ongoing and upcoming developments, especially in the area of our air filtration solutions and ultrasound scanners for use in human and veterinary medicine, continue to attract the market's growing interest," indicated Mr. André Leroux, Chairman of the Board and Chief Executive Officer of the Company.

The securities offered have not been registered, and will not be registered, under the United States Securities Act of 1933, as amended, and may not be sold in the United States absent registration or an applicable exemption from the registration requirements. This press release does not constitute an offer to sell or the solicitation of any offer to buy nor will there be any sale of these securities in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such province, state or jurisdiction.

Source:

NOVEKO INTERNATIONAL INC.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows exercise can reverse age-related lipid accumulation